| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.27 | 0.09 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.09 |